Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Appendix 3B

6 Aug 2012 07:42

RNS Number : 3482J
Oilex Limited
06 August 2012
 



 

 

 

 

 

 

6 August 2012

 

Dear Sirs

 

Appendix 3B

 

Oilex Ltd (the "Company") refers to its recent announcement relating to a capital raising by way of a fully underwritten pro-rata renounceable entitlement offer.

 

The Company advises that a pro-rata renounceable entitlement offer of 101,329,954 fully paid ordinary shares at an issue price of $0.07 is to be made. The Company will also issue 50,664,977 options with an exercise price of $0.15 expiring 7 September 2015 on the basis of one option for every 2 shares subscribed for.

 

For and on behalf of Oilex Ltd

 

 

 

 

Ben Clube

Finance Director / Company Secretary

 

 

 

 

cc: Directors - BMc/RB/MC/SB/RM

 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

 

 

Appendix 3B

 

New issue announcement,application for quotation of additional securitiesand agreement

 

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

 

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005, 01/08/2012.

 

 

Name of entity

 OILEX LTD

 

ABN

50 078 652 632

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1.

+Class of +securities issued or to be issued

 

(a) Ordinary Shares

(b) Options

2.

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

 

(a) 101,329,954 fully paid ordinary shares

 

(b) 50,664,977 options

3.

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

 

(a) Fully paid ordinary shares

 

(b) Options with an exercise price of $0.15 expiring on 7 September 2015

 

 

4.

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

(a) Yes. Ordinary shares will rank equally with existing ordinary shares

 

(b) Options will not rank equally. Shares issued upon exercise of options will rank equally with existing ordinary shares

 

 

 

 

 

5.

Issue price or consideration

 

(a) Ordinary shares $0.07

 

(b) Options - Nil

 

 

 

 

6.

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

To provide funds to drill an offset well near the Cambay-76H well and conduct a production test to assess the commerciality of the Cambay Y Zone tight reservoirs in the Cambay Contract Area, and for general working capital.

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

 

 

6b

The date the security holder resolution under rule 7.1A was passed

N/A

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

N/A

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

N/A

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

N/A

 

6f

Number of securities issued under an exception in rule 7.2

N/A

 

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

N/A

 

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

N/A

 

7.

Dates of entering +securities into uncertificated holdings or despatch of certificates

 

 

 

Allotment date 7 September 2012

 

 

Number

+Class

8.

Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

 

354,654,839

 

50,664,977

 

Ordinary Shares

 

Options

 

Number

+Class

9.

Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

2,000,000

16,687,500

75,000

4,150,000

8,737,500

75,000

 

 

 

$0.30 Options due 15/09/2012

$0.30 Options due 10/11/2012

$0.50 Options due 01/08/2013

$0.30 Options due 01/07/2014

$0.37 Options due 10/11/2014

$0.63 Options due 01/08/2015

 

2008 Performance Rights

 

22,000

Tranche 3 expire 1/07/2013

10.

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

 

N/A

 

 

Part 2 ‑ Bonus issue or pro rata issue [Item 11 to 33 - Not Applicable]

 

11

Is security holder approval required?

 

No

 

 

12

Is the issue renounceable or non-renounceable?

Renounceable

 

13

Ratio in which the +securities will be offered

2 new shares for every 5 shares held and one attaching option for every 2 new shares subscribed for

 

14

+Class of +securities to which the offer relates

(a) Ordinary fully paid shares

 

(b) Options to acquire ordinary fully paid shares

 

15

+Record date to determine entitlements

5.00pm WST 15 August 2012

 

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

N/A

 

17

Policy for deciding entitlements in relation to fractions

 

Fractional entitlements will be rounded up to the nearest whole number of shares or options

 

18

Names of countries in which the entity has +security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

China

Channel Islands

Czech Republic

Spain

Greece

Hong Kong

Switzerland

United Arab Emirates

India

Ireland

Japan

Netherlands

Sultanate of Oman

Papua New Guinea

Portugal

Singapore

Thailand

United States of America

British Virgin Islands

 

 

19

Closing date for receipt of acceptances or renunciations

30 August 2012

 

20

Names of any underwriters

 

 

Patersons Securities Limited

 

21

Amount of any underwriting fee or commission

$425,586 management and underwriting fee plus 101,329,954 options to acquire ordinary shares at an exercise price of $0.07 expiring 7 September 2015

 

22

Names of any brokers to the issue

 

 

Patersons Securities Limited

 

23

Fee or commission payable to the broker to the issue

$60,000

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of +security holders

N/A

 

25

If the issue is contingent on +security holders' approval, the date of the meeting

N/A

 

26

Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled

16 August 2012

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

6 August 2012

 

28

Date rights trading will begin (if applicable)

9 August 2012

 

29

Date rights trading will end (if applicable)

 

 

23 August 2012

 

30

How do +security holders sell their entitlements in full through a broker?

Complete back of Entitlement and Acceptance Form and send to broker

 

31

How do +security holders sell part of their entitlements through a broker and accept for the balance?

Complete back of Entitlement and Acceptance Form and send to broker together with the rights to be accepted

 

32

How do +security holders dispose of their entitlements (except by sale through a broker)?

Complete a standard renunciation or transfer form (obtainable from broker or share registry) and send together with Entitlement and Acceptance Form

 

33

+Despatch date

 

 

7 September 2012

 

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

(a)

Securities described in Part 1

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

 

Entities that have ticked box 34(a) [Items 35 to 42 - Not Applicable]

Additional securities forming a new class of securities

 

Quotation agreement

 

1. +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2. We warrant the following to ASX.

 

·; The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

·; There is no reason why those +securities should not be granted +quotation.

·; An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·; Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

·; We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the +securities to be quoted, it has been provided at the time that we request that the +securities be quoted.

·; If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3. We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4. We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

 

 

 

Sign here: .............................................. Date: 6 August 2012

 

(Finance Director / Company Secretary)

 

 

Print name: Ben Clube

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFFRTRIRIIF
Date   Source Headline
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
28th Jan 202212:50 pmRNSAppointment of Director
28th Jan 202212:47 pmRNSDecember 2021 Quarterly Report
18th Jan 20227:13 amRNSGM – Notice of Meeting
17th Jan 202212:19 pmRNSPlacing - Issue of Securities
4th Jan 20227:00 amRNSPlacement – Issue of Securities
29th Dec 20212:29 pmRNSChange of Interests of Substantial Holder
23rd Dec 20217:00 amRNSIssue of Securities
22nd Dec 20217:00 amRNSUnmarketable Parcel Facility Update
15th Dec 20218:47 amRNSCambay Production Re-start Update
13th Dec 20213:56 pmRNSCambay Well 77H Re-Frac Funding Secured
30th Nov 20217:00 amRNSUnmarketable Parcel Facility Update
29th Nov 20217:00 amRNSResult of Annual General Meeting
11th Nov 20217:00 amRNSIssue of Shares and Section 708A(5)(e) Notice
29th Oct 202110:40 amRNSAward of Well Management Services Contract
28th Oct 20217:34 amRNSSeptember 2021 Quarterly Report
27th Oct 20217:00 amRNSNotice of AGM
4th Oct 20211:39 pmRNSAGM Date / Closing Date for Director Nominations
28th Sep 20212:06 pmRNSSecond Price Monitoring Extn
28th Sep 20212:00 pmRNSPrice Monitoring Extension
22nd Sep 20213:59 pmRNSCorporate Governance Statement
22nd Sep 20213:59 pmRNSAnnual Report 2021
17th Sep 20214:41 pmRNSSecond Price Monitoring Extn
17th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 202111:13 amRNSCambay Update and UK Exploration Licence P2446
7th Sep 20219:53 amRNSASX Unmarketable Parcel Share Disposal
26th Aug 20217:00 amRNSAppointment of New Company Secretary
12th Aug 20217:01 amRNSAppendix 3Y P Haywood
12th Aug 20217:01 amRNSAppendix 3Y P Schwarz
12th Aug 20217:00 amRNSIssue of Shares and Section 708A(5)(e) Notice
30th Jul 20217:00 amRNSJune 2021 Quarterly Report
21st Jul 20217:24 amRNSAIM Rule 17 Disclosure
2nd Jul 20218:15 amRNSAppointment of New CFO
25th Jun 20217:00 amRNSAppendix 3Y P Schwarz
25th Jun 20217:00 amRNSAppendix 3Y P Haywood
24th Jun 20217:00 amRNSIssue of Securities
22nd Jun 202110:48 amRNSIssue of Securities
21st Jun 202111:19 amRNSIssue of Securities
17th Jun 20218:41 amRNSAppendix 3X Roland Wessel
16th Jun 20218:30 amRNSAppointment of New CEO & Director
10th Jun 202112:05 pmRNSExecution of Cambay SPA
10th Jun 202110:13 amRNSIssue of Securities
8th Jun 20217:00 amRNSResults of General Meeting
7th Jun 20212:05 pmRNSSecond Price Monitoring Extn
7th Jun 20212:00 pmRNSPrice Monitoring Extension
28th May 20217:00 amRNSBhandut Sale Completed
21st May 20217:35 amRNSAppendix 3Y P Schwarz
21st May 20217:34 amRNSAppendix 3Y P Haywood
18th May 20217:00 amRNSGM - Notice of Meeting - Change of Venue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.